Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides*

Jordi Rello,Jordi Solé-Violán,Marcio Sa-Borges,José Garnacho-Montero,Emma Muñoz,Gonzalo Sirgo,Montserrat Olona,Emili Diaz

Pneumonia caused by oxacillin-resistant Staphylococcus aureus treated with glycopeptides*

2005

Jordi Rello
Jordi Solé-Violán
Marcio Sa-Borges
José Garnacho-Montero
Emma Muñoz
Gonzalo Sirgo
Montserrat Olona
Emili Diaz

Objective:To determine whether ventilator-associated pneumonia caused by oxacillin-resistant Staphylococcus aureus (VAP-ORSA) treated with glycopeptides is associated with an increased mortality rate.Design:Retrospective matched cohort study.Setting:Four intensive care units in teaching hospitals.Pa

Keywords:

Meticillin
Methicillin-resistant Staphylococcus aureus
Intensive care medicine
Micrococcaceae
Glycopeptide
Staphylococcus aureus
Antibiotics
Ventilator-associated pneumonia
Vancomycin
Medicine
Population
antibacterial agent
intensive care
Intensive care unit
Mortality rate
Interquartile range

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

141

Citations